| 发明名称 | Immunomodulation using placental stem cells | ||
| 摘要 | The present invention provides methods of immunomodulation using placental stem cells and placental stem cell populations. The invention also provides methods of producing and selecting placental cells and cell populations on the basis of immunomodulation, and compositions comprising such cells and cell populations. | ||
| 申请公布号 | US8895256(B2) | 申请公布日期 | 2014.11.25 |
| 申请号 | US201213474378 | 申请日期 | 2012.05.17 |
| 申请人 | Anthrogenesis Corporation | 发明人 | Paludan Casper;Edinger James;Harbacheuski Ryhor;Murray RoseAnn;Hariri Robert J. |
| 分类号 | A61K35/50;C12N5/073;C12N5/0775 | 主分类号 | A61K35/50 |
| 代理机构 | Jones Day | 代理人 | Jones Day |
| 主权项 | 1. A method of suppressing or reducing a disease-associated immune response in a subject comprising administering a therapeutically effective amount of placental stem cells to the subject, wherein said placental stem cells suppress T cell proliferation stimulated by Epstein-Barr virus antigen-presenting B cells; and wherein at least 80% of said placental stem cells express CD200. | ||
| 地址 | Warren NJ US | ||